AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogipax GM 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Vidakem Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Vogipax GM 1mg/500mg/0.2mg Tablet

Diabex Trio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This triple-combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including a healthy diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to treat it. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to check blood cell counts and liver function.

Uses of Vogipax GM 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Vogipax GM 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vogipax GM 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Vogipax GM 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vogipax GM 1mg/500mg/0.2mg Tablet:

Administer Vogipax GM 1mg/500mg/0.2mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication on an empty stomach.

How Vogipax GM 1mg/500mg/0.2mg Tablet works:

The tablet Vogipax GM, containing 1mg/500mg/0.2mg of three distinct antidiabetic agents, is a triple-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vogipax GM 1mg/500mg/0.2mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vogipax GM 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vogipax GM 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Vogipax GM 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, Vogipax GM 1mg/500mg/0.2mg Tablets are not advised for those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Vogipax GM 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, the medication is contraindicated in those with severe liver disease.

What if you forget to take Vogipax GM 1mg/500mg/0.2mg Tablet :

Should you forget to take a Vogipax GM 1mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vogipax GM 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vogipax GM 1mg/500mg/0.2mg Tablet

Vogipax GM (Glimepiride/Metformin/Voglibose) tablets treat type 2 diabetes mellitus in adults. This combination medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is not suitable for type 1 diabetes.
Vogipax GM 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, rash, and respiratory infection.
Vogipax GM 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any constituent or excipient. Use is also contraindicated in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulceration, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Vogipax GM 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vogipax GM 1mg/500mg/0.2mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vogipax GM 1mg/500mg/0.2m...
77
MRP 89
13% off